Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares? [Globe and Mail, The (Toronto, Canada)]
Adaptive Biotechnologies Corporation (ADPT)
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adhc.com
Company Research
Source: Globe and Mail, The
This sale represented 12.29% of Rubinstein's direct holdings at the time, reducing her directly held Common Stock to 408,160 shares. The shares sold were acquired through the exercise of options immediately prior to sale; no indirect holdings or gifts were involved. Julie Rubinstein, President and COO of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) , reported the direct sale of 57,180 shares of Common Stock in a series of open-market transactions between April 14 and April 16, 2026, with shares sold at a weighted average price of around $14.45 per share, according to the SEC Form 4 filing Transaction summary Metric Value Shares sold (direct) Transaction value ~$826,000 Post-transaction shares (direct) Post-transaction value (direct ownership) ~$5.75 million Transaction value based on SEC Form 4 weighted average purchase price ($14.45); post-transaction value based on April 16, 2026, market close ($14.08). Key questions What was the structure and purp
Show less
Read more
Impact Snapshot
Event Time:
ADPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADPT alerts
High impacting Adaptive Biotechnologies Corporation news events
Weekly update
A roundup of the hottest topics
ADPT
News
- Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares? [Yahoo! Finance]Yahoo! Finance
- Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026GlobeNewswire
- A Look At Adaptive Biotechnologies (ADPT) Valuation After Q4 2025 Beat And New Pfizer Agreements [Yahoo! Finance]Yahoo! Finance
- Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look [Yahoo! Finance]Yahoo! Finance
- Adaptive Biotechnologies (ADPT) Moves 5.8% Higher: Will This Strength Last? [Yahoo! Finance]Yahoo! Finance
ADPT
Earnings
- 2/5/26 - Beat
ADPT
Sec Filings
- 4/16/26 - Form 4
- 4/13/26 - Form 4
- 4/10/26 - Form 4
- ADPT's page on the SEC website